ESKAG pharma

Quality & approvals

Our quality policy is a result of integration of world class guidelines, adherence to global laws and regulations in pharma industry and our commitment to compliance. Besides, the core strength of our quality policy is that it is designed looking from the customer’s point of view, which means we assess our quality parameters very critically.

Our quality system is designed, documented, implemented and controlled in such a way that there is no room for error. This is evident from the fact that we have had no instance of recall of any of our products from the market.

Our quest for high quality is being complemented by various departments like R&D, Materials, Production, Engineering, Stores, Medical, Marketing, EDP, Quality Control and Quality Assurance.

Our quality policy is mandated and supported by executive management and though is coordinated by Quality Assurance, it is responsibility of everyone. It is monitored by a team responsible for Validation, GMP documentation, Self–audits, Training and Market complaints.

Pharmaceutical quality & responsibility

As expected from a company engaged in formulation, development, manufacturing and worldwide distribution of pharmaceutical products, Eskag Pharma feature high significance and priority to the subject of pharmaceutical quality & responsibility. Our products are usually of the maximum efficacy, having minimal side effects and are intended to be as user friendly as achievable.

From the most senior members of management to the last of our employees Eskag Pharma’s employees are devoted towards ensuring the safety of our products as well as, so far as our relative role may assist us, those of our numerous business partners.

Eskag Pharma’s policy is never to give way to “cutting corners” in any subject about the meeting of all World Health Organization, FDA, EMA and any further local authorities’ necessities. In order to do this we in no way excuse ourselves from promising the security of our products by all other means obtainable to us. This policy reveals the level of accountability we command of ourselves.

In the field of pharmaceuticals there is generally strict regulatory requirements intended to ensure that any medications, whether they are of the “over the counter” OTC (no prescription needed) type or medications which can only be prescribed by physicians, are as safe for human use as they can possibly be. Almost all medications have possible unwanted side effects. These are always taken into watchful consideration but as long as they are comparatively minor and that the benefits from using a particular medication far exceed the risks involved in use of this medication is measured safe.

When broken down into section accountability for safe, high quality products consists of multiple stages, some of them overlap. Any new pharmaceutical product start with formulation, concerns for customer safety play a necessary position even at these very early on phase.

With Eskag Pharma’s the meeting of all regulatory requirements of the WHO, FDA and EMA serve only as the minimal marker for ensuring short and long term user safety. Bioequivalence, bioavailability, clinical trials, and regulatory submissions are all managed in the highest specialized way.

Eskag Pharma’s policies concerning our accountability towards any and all who use our products has earned us a standing for being a pharmaceutical company whose quality pharma products are among the safest in the world.
Our delivery logistics are of the strictest principles. All shipments are constantly monitored for preferred temperature reliability, delicate handling, sufficient transportation storage space etc.